Susquehanna International Group, LLP Otonomy, Inc. Transaction History

Susquehanna International Group, LLP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.25 - $2.24 $4,536 - $40,642	-18,144 Reduced 25.29%	53,600 $16,000
Q2 2022 Aug 15, 2022	BUY	$1.72 - $2.51 $93,672 - $136,697	54,461 Added 315.11%	71,744 $150,000
Q1 2022 May 16, 2022	SELL	$1.72 - $2.47 $333,296 - $478,629	-193,777 Reduced 91.81%	17,283 $41,000
Q2 2021 Aug 11, 2021	SELL	$2.06 - $2.67 $761,071 - $986,436	-369,452 Reduced 63.64%	211,060 $471,000
Q1 2021 May 17, 2021	BUY	$2.49 - $6.23 $1.26 Million - $3.16 Million	506,449 Added 683.81%	580,512 $1.48 Million
Q4 2020 Feb 16, 2021	BUY	$3.48 - $6.47 $159,933 - $297,348	45,958 Added 163.52%	74,063 $479,000
Q3 2020 Nov 16, 2020	BUY	$3.16 - $4.36 $50,481 - $69,651	15,975 Added 131.7%	28,105 $114,000
Q2 2020 Aug 14, 2020	SELL	$1.87 - $3.84 $27,053 - $55,553	-14,467 Reduced 54.39%	12,130 $44,000
Q1 2020 May 15, 2020	SELL	$1.58 - $4.06 $78,590 - $201,948	-49,741 Reduced 65.16%	26,597 $52,000
Q4 2019 Feb 14, 2020	BUY	$2.13 - $3.83 $123,128 - $221,400	57,807 Added 311.95%	76,338 $292,000
Q2 2018 Aug 14, 2018	SELL	$3.7 - $4.75 $315,965 - $405,631	-85,396 Reduced 82.17%	18,531 $71,000
Q1 2018 May 15, 2018	SELL	$4.05 - $6.1 $147,371 - $221,966	-36,388 Reduced 25.93%	103,927 $436,000
Q4 2017 Feb 14, 2018	BUY	$2.8 - $5.55 $253,293 - $502,064	90,462 Added 181.46%	140,315 $779,000
Q3 2017 Nov 14, 2017	BUY	$3.2 - $20.8 $159,529 - $1.04 Million	49,853	49,853 $162,000

Ticker OTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,990,400
Description
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.